Skip to content

SPAC Feed

Curated SPACs News

  • News
  • Opinions
  • Events
  • Videos
  • Resources
  • Contact Us
  • News
Posted on October 26, 2026

Obesity drug developer Corxel to go public in US via SPAC deal – Reuters

Obesity drug developer Corxel to go public in US via SPAC deal  Reuters
By sf-admin

Post navigation

Corxel to take oral GLP-1 public in the US via SPAC – Endpoints News
Corxel, an obesity drugmaker, to go public via SPAC deal – BioPharma Dive


  • About Us
  • Contact Us
  • Subscribe
Copyright © 2026 SPAC Feed. All Rights Reserved | News Vibe by Theme Palace